Stay updated on Tempol (MBM-02) in COVID-19 Patients Clinical Trial
Sign up to get notified when there's something new on the Tempol (MBM-02) in COVID-19 Patients Clinical Trial page.

Latest updates to the Tempol (MBM-02) in COVID-19 Patients Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange Detected- Updated the page to include a government-operating-status notice and a new version tag (v3.2.0), replacing the old v3.1.0.SummaryDifference4%
- Check17 days agoChange DetectedApparent page reversion to a new version (v3.1.0) while removing several drug-safety and drug-category topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs), indicating content consolidation.SummaryDifference0.5%
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2, with the Back to Top element removed; no other substantive changes.SummaryDifference0.2%
- Check38 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, names, pricing, or availability.SummaryDifference0.2%
- Check46 days agoChange DetectedThe web page has undergone significant changes, including the addition of a facility name and location, as well as new content related to drug safety and counterfeit drugs. Notably, the previous version's detailed pharmacological content has been removed.SummaryDifference2%
- Check60 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
Stay in the know with updates to Tempol (MBM-02) in COVID-19 Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tempol (MBM-02) in COVID-19 Patients Clinical Trial page.